BioStock: Fluicell’s CRO services diversify revenue opportunities
Fluicell’s main objective is to empower researchers in the healthcare sector to push the bounds of science. The life science company manages this not only by offering a range of innovative single-cell research tools, but also by providing CRO services to researchers aiming for new drug discoveries. The activities, along with academic partnerships, are strong drivers of Fluicell’s growth.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se